Literature DB >> 16107323

An isoform shift in the cardiac adenine nucleotide translocase expression alters the kinetic properties of the carrier in dilated cardiomyopathy.

Andrea Dörner1, Stefanie Giessen, Regina Gaub, Helga Grosse Siestrup, Peter L Schwimmbeck, Roland Hetzer, Wolfgang Poller, Heinz-Peter Schultheiss.   

Abstract

BACKGROUND: Impaired mitochondrial ADP/ATP transport and altered adenine nucleotide translocase (ANT) isoform expression characterized by enhanced ANT1 and decreased ANT2 expression have been implicated in the pathophysiology of dilated cardiomyopathy (DCM). It is still unknown whether restricted ANT function results from exogenous factors, or mutations in the ANT genes, or whether the imbalance in the isoform composition causes the reduced ADP/ATP transport. We performed DNA mutation screening of ANT genes and analyzed the kinetic properties of ANT protein isolated from DCM hearts and controls in a reconstituted system excluding natural environmental influences.
RESULTS: A G1409T polymorphism in ANT2 leads to an exchange from Arg111 to Leu111 in healthy blood donors (n = 60) with allele frequencies of 76% and 24%. This polymorphism was neither associated with DCM (74%, 26%; n = 93) nor with altered myocardial ANT isoform expression or restricted ANT function (89%, 11%; n = 8). However, there was a remarkable reduction in the maximum transport activity (v(max)) of reconstituted ANT from DCM hearts with altered ANT isoform expression (498 +/- 113 micromol min(-1) g(-1) incorporated protein vs. 1112 +/- 178 micromol min(-1) g(-1) incorporated protein, p < 0.01). Moreover, the substrate affinity of DCM myocardial ANT to ATP was slightly reduced with an increased K(m) value of 104.3 +/- 2.4 microM vs. 90.4 +/- 2.9 microM in controls (p < 0.03).
CONCLUSION: The altered isoform expression in DCM hearts entails changes in the kinetic properties of total ANT protein restricting ANT function and contributing to disturbed energy metabolism in DCM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16107323     DOI: 10.1016/j.ejheart.2005.05.003

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  16 in total

Review 1.  New aspects of impaired mitochondrial function in heart failure.

Authors:  Mariana G Rosca; Charles L Hoppel
Journal:  J Bioenerg Biomembr       Date:  2009-04       Impact factor: 2.945

2.  Carboxyatractyloside effects on brown-fat mitochondria imply that the adenine nucleotide translocator isoforms ANT1 and ANT2 may be responsible for basal and fatty-acid-induced uncoupling respectively.

Authors:  Irina G Shabalina; Tatiana V Kramarova; Jan Nedergaard; Barbara Cannon
Journal:  Biochem J       Date:  2006-11-01       Impact factor: 3.857

3.  Downregulation of adenine nucleotide translocator 1 exacerbates tumor necrosis factor-α-mediated cardiac inflammatory responses.

Authors:  Shi Pan; Nadan Wang; Sara Bisetto; Bing Yi; Shey-Shing Sheu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-11-07       Impact factor: 4.733

4.  Transient upregulation of PGC-1alpha diminishes cardiac ischemia tolerance via upregulation of ANT1.

Authors:  Edward G Lynn; Mark V Stevens; Renee P Wong; Darin Carabenciov; Jeremy Jacobson; Elizabeth Murphy; Michael N Sack
Journal:  J Mol Cell Cardiol       Date:  2010-07-01       Impact factor: 5.000

Review 5.  Dynamic organization of mitochondria in human heart and in myocardial disease.

Authors:  Charles L Hoppel; Bernard Tandler; Hisashi Fujioka; Alessandro Riva
Journal:  Int J Biochem Cell Biol       Date:  2009-05-14       Impact factor: 5.085

Review 6.  Mitochondria in the human heart.

Authors:  H Lemieux; C L Hoppel
Journal:  J Bioenerg Biomembr       Date:  2009-04       Impact factor: 2.945

Review 7.  Mitochondria in cardiac hypertrophy and heart failure.

Authors:  Mariana G Rosca; Bernard Tandler; Charles L Hoppel
Journal:  J Mol Cell Cardiol       Date:  2012-09-13       Impact factor: 5.000

8.  Submaximal ADP-stimulated respiration is impaired in ZDF rats and recovered by resveratrol.

Authors:  Brennan K Smith; Christopher G R Perry; Eric A F Herbst; Ian R Ritchie; Marie-Soleil Beaudoin; Jeffrey C Smith; P Darrell Neufer; David C Wright; Graham P Holloway
Journal:  J Physiol       Date:  2013-09-30       Impact factor: 5.182

Review 9.  Mitochondrial dysfunction in heart failure.

Authors:  Mariana G Rosca; Charles L Hoppel
Journal:  Heart Fail Rev       Date:  2013-09       Impact factor: 4.214

10.  Left ventricular global transcriptional profiling in human end-stage dilated cardiomyopathy.

Authors:  Dilek Colak; Namik Kaya; Jawaher Al-Zahrani; Albandary Al Bakheet; Paul Muiya; Editha Andres; John Quackenbush; Nduna Dzimiri
Journal:  Genomics       Date:  2009-03-28       Impact factor: 5.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.